| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0045 |
0.9 |
| mRNA |
BRD-K66532283 |
CTRPv2 |
pan-cancer |
AAC |
0.0041 |
0.9 |
| mRNA |
BRD-K13185470 |
CTRPv2 |
pan-cancer |
AAC |
0.0084 |
0.9 |
| mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
0.0056 |
0.9 |
| mRNA |
BRD-K03911514 |
CTRPv2 |
pan-cancer |
AAC |
-0.006 |
0.9 |
| mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.004 |
0.9 |
| mRNA |
SB 505124 |
GDSC1000 |
pan-cancer |
AAC |
-0.0039 |
0.9 |
| mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
0.0037 |
0.9 |
| mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0039 |
0.9 |
| mRNA |
pifithrin-alpha |
CTRPv2 |
pan-cancer |
AAC |
-0.004 |
0.9 |